Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_14869 | 56 | 1.17 | Mlig455_041087 | Neo: - Age: - |
Mlig455_041087 {REF} {Length: 1408} {RNA1310_35281} {RNA815_59011} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -1.565 | 1.032 | 1.00000 | 1.00000 | |
RegionR2 | -0.93 | 1.032 | 0.99481 | 1.00000 | |
RegionR3 | -3.455 | 1.032 | 0.99949 | 1.00000 | |
RegionR4 | 3.06 | 1.032 | 0.14461 | 0.39025 | |
RegionR5 | -0.614 | 1.032 | 0.41913 | 0.77899 | |
RegionR6 | -3.429 | 1.032 | 1.00000 | 1.00000 | |
RegionR7 | 3.679 | 1.032 | 0.09625 | 0.59404 | |
RegionR8 | 3.255 | 1.032 | 0.47174 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -0.444 | 1.032 | 0.99974 | 1.00000 | |
RegenerationR2 | -0.808 | 1.032 | 0.51595 | 0.87824 | |
RegenerationR3 | -2.184 | 1.032 | 0.99978 | 1.00000 | |
RegenerationR4 | -3.884 | 1.032 | 0.13187 | 0.54923 | |
RegenerationR5 | -2.685 | 1.032 | 0.20181 | 0.63410 | |
RegenerationR6 | -1.486 | 1.032 | 1.00000 | 1.00000 | |
RegenerationBL | -0.969 | 1.032 | 0.99850 | 1.00000 | |
RegenerationTP | -4.056 | 1.032 | 0.18907 | 0.62731 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_14869 | 56 | 1.17 | Mlig455_041087 | Neo: - Age: - |
4 | 1.000 | - | 1.000 | 1.000 | - | 1.000 | Mlig455_041087 {REF} {Length: 1408} {RNA1310_35281} {RNA815_59011} | |
2. | MligTC455_10719 | 61 | 1.26 | Mlig455_041088 | Neo: - Age: - |
3.861 | 0.988 | - | 0.886 | 0.998 | - | 0.989 | Mlig455_041088 {REF} {Length: 338} {NoTransDecoderORF} {RNA1310_18998} | |
3. | MligTC455_46583 | 1098 | 22.87 | Mlig455_067509 | Neo: - Age: logFC(26M/2M)=-0.318 Region-enriched R8: 2.830/0.00000 Regeneration-depleted TP: -3.677 |
3.377 | 0.793 | - | 0.779 | 0.853 | - | 0.952 | Mlig455_067509 {REF} {Length: 1536} {Pfam: Low-density lipoprotein receptor domain class A [PF00057.20, score=25.3]} {Dmel: FBgn0051221, CG31221, [Score=62.8, Expect=5e-12]} {Celegans: WBGene00010290, F58H1.7, [RH, Score=66.6, Expect=1e-13]} {Smed: dd_Smed_v6_2598_0_1, dd_Smed_v6_2598_0_1, [RH, Score=173, Expect=3e-55]} {RNA1509_59060} {RNA1310_28256} {RNA815_15141.1} | |
4. | MligTC455_12255 | 87 | 1.82 | Mlig455_042299 | Neo: - Age: Down-Up-Down Region-enriched R8: 4.103/0.00190 |
2.708 | 0.770 | - | - | 0.956 | - | 0.982 | Mlig455_042299 {REF} {Length: 2190} {Smed: dd_Smed_v6_18803_0_1, dd_Smed_v6_18803_0_1, [Score=244, Expect=3e-75]} {RNA1310_26226} {RNA815_49309} | |
5. | MligTC455_54035 | 84 | 1.74 | Mlig455_017217 | Neo: - Age: Down-Up-Down |
CALML5 | 2.623 | 0.955 | - | - | 0.834 | - | 0.834 | Mlig455_017217 {REF} {Length: 1760} {Pfam: EF hand [PF00036.34, score=48.2]; EF-hand domain pair [PF13499.8, score=45.0]; EF-hand domain [PF13405.8, score=40.7]; EF hand [PF13202.8, score=34.7]; EF-hand domain pair [PF13833.8, score=29.2]} {Human: ENSG00000178372, CALML5, calmodulin like 5, [Score=50.4, Expect=7e-08]} {Mouse: ENSMUSG00000097733, Cabp2, calcium binding protein 2, [Score=45.8, Expect=5e-06]; ENSMUSG00000024857, Cabp2, calcium binding protein 2, [Score=45.8, Expect=5e-06]} {Celegans: WBGene00000287, cal-3, CALmodulin related genes, [Score=50.4, Expect=7e-08]} {Smed: dd_Smed_v6_4512_0_1, dd_Smed_v6_4512_0_1, [Score=45.8, Expect=2e-06]} {RNA1509_44750} {RNA1310_71381} {RNA815_19875} |
6. | MligTC455_24861 | 117 | 2.44 | Mlig455_019572 | Neo: - Age: - Region-enriched R8: 4.245/0.00630 |
FREM1 | 2.612 | 0.978 | - | - | 0.746 | - | 0.888 | Mlig455_019572 {REF} {Length: 8695} {Pfam: Cadherin-like [PF16184.7, score=328.8]; Frem protein N-terminal domain [PF19309.1, score=92.3]; Lectin C-type domain [PF00059.23, score=31.6]} {Human: ENSG00000164946, FREM1, FRAS1 related extracellular matrix 1, [RH, Score=370, Expect=2e-102]} {Mouse: ENSMUSG00000059049, Frem1, Fras1 related extracellular matrix protein 1, [RH, Score=381, Expect=3e-106]} {Smed: dd_Smed_v6_5187_0_1, dd_Smed_v6_5187_0_1, [RH, Score=508, Expect=4e-147]} {RNA1509_8234} {RNA1310_595.1} {RNA815_322} |
7. | MligTC455_38656 | 100 | 2.08 | Mlig455_021354 | Neo: - Age: - |
CPLX1 | 2.578 | 0.840 | - | - | 0.787 | - | 0.951 | Mlig455_021354 {REF} {Length: 2078} {Pfam: Synaphin protein [PF05835.14, score=132.9]} {Human: ENSG00000168993, CPLX1, complexin 1, [Score=52.4, Expect=8e-09]; ENSG00000145920, CPLX2, complexin 2, [Score=50.8, Expect=1e-08]} {Mouse: ENSMUSG00000033615, Cplx1, complexin 1, [Score=53.5, Expect=2e-09]} {Dmel: FBgn0041605, cpx, complexin, [RH, Score=90.1, Expect=1e-23]} {Celegans: WBGene00022271, cpx-1, Putative complexin-1, [RH, Score=99.4, Expect=2e-27]} {Smed: dd_Smed_v6_9918_0_1, dd_Smed_v6_9918_0_1, [Score=94.4, Expect=2e-25]} {RNA1509_37151} {RNA1310_45759, RNA1509_37151} {RNA1509_37151, RNA815_22799} |
8. | MligTC455_39396 | 469 | 9.77 | Mlig455_031203 | Neo: - Age: - Region-enriched R8: 3.069/0.00001 |
ARRDC3 | 2.514 | 0.967 | - | - | 0.708 | - | 0.839 | Mlig455_031203 {REF} {Length: 1835} {Pfam: Arrestin (or S-antigen), N-terminal domain [PF00339.31, score=114.8]; Arrestin (or S-antigen), C-terminal domain [PF02752.24, score=66.5]; Rgp1 [PF08737.12, score=23.6]} {Human: ENSG00000113369, ARRDC3, arrestin domain containing 3, [Score=112, Expect=5e-27]} {Mouse: ENSMUSG00000074794, Arrdc3, arrestin domain containing 3, [Score=113, Expect=1e-27]} {Dmel: FBgn0037517, CG10086, [RH, Score=85.1, Expect=1e-17]} {Celegans: WBGene00009579, arrd-6, ARRestin Domain protein, [RH, Score=322, Expect=2e-106]} {RNA1509_30037} {RNA1310_19411, RNA1509_30037} {RNA1509_30037, RNA815_7851} |
9. | MligTC455_22649 | 85 | 1.77 | Mlig455_059428 | Neo: - Age: - |
2.41 | 0.953 | - | 0.717 | - | - | 0.740 | Mlig455_059428 {REF} {Length: 2992} {Pfam: Sushi repeat (SCR repeat) [PF00084.22, score=28.2]} {Smed: dd_Smed_v6_41498_0_1, dd_Smed_v6_41498_0_1, [Score=152, Expect=1e-39]} {RNA1509_58668} {RNA1310_14740.1} {RNA815_23861} | |
10. | MligTC455_52402 | 223 | 4.65 | Mlig455_048722 | Neo: - Age: - Region-enriched R8: 5.458/0.00000 |
1.988 | 0.992 | - | - | - | - | 0.996 | Mlig455_048722 {REF} {Length: 961} {TRANSSPLICED} {RNA1310_39954.1} {RNA815_19596} | |
11. | MligTC455_17475 | 56 | 1.16 | Mlig455_065300, Mlig455_065322 | Neo: - Age: - |
MYT1L | 1.899 | 0.953 | - | 0.946 | - | - | - | Mlig455_065300 {REF} {Length: 3149} {Pfam: Zinc finger, C2HC type [PF01530.20, score=77.6]} {Human: ENSG00000186487, MYT1L, myelin transcription factor 1 like, [RH, Score=130, Expect=2e-33]; ENSG00000196132, MYT1, myelin transcription factor 1, [RH, Score=126, Expect=1e-29]; ENSG00000276876, MYT1, myelin transcription factor 1, [RH, Score=126, Expect=1e-29]; ENSG00000147488, ST18, ST18, C2H2C-type zinc finger, [RH, Score=126, Expect=3e-30]; ENSG00000275018, AL121581.1, novel transcript, [RH, Score=125, Expect=1e-29]} {Mouse: ENSMUSG00000061911, Myt1l, myelin transcription factor 1-like, [RH, Score=129, Expect=6e-31]; ENSMUSG00000010505, Myt1, myelin transcription factor 1, [RH, Score=125, Expect=7e-30]; ENSMUSG00000033740, St18, suppression of tumorigenicity 18, [RH, Score=125, Expect=1e-29]} {Dmel: FBgn0263772, CG43689, [Score=87.4, Expect=1e-17]} {Celegans: WBGene00009939, ztf-11, Zinc finger putative Transcription Factor family, [RH, Score=123, Expect=1e-29]} {Smed: dd_Smed_v6_80183_0_1, dd_Smed_v6_80183_0_1, [RH, Score=132, Expect=7e-35]} {RNA1310_120779} Mlig455_065322 {REF} {Length: 1854} {Pfam: Zinc finger, C2HC type [PF01530.20, score=74.9]} {Human: ENSG00000186487, MYT1L, myelin transcription factor 1 like, [RH, Score=129, Expect=1e-31]; ENSG00000147488, ST18, ST18, C2H2C-type zinc finger, [RH, Score=126, Expect=3e-30]; ENSG00000276876, MYT1, myelin transcription factor 1, [RH, Score=125, Expect=8e-30]; ENSG00000196132, MYT1, myelin transcription factor 1, [RH, Score=125, Expect=8e-30]; ENSG00000275018, AL121581.1, novel transcript, [RH, Score=125, Expect=9e-30]} {Mouse: ENSMUSG00000061911, Myt1l, myelin transcription factor 1-like, [RH, Score=128, Expect=7e-31]; ENSMUSG00000010505, Myt1, myelin transcription factor 1, [RH, Score=125, Expect=6e-30]; ENSMUSG00000033740, St18, suppression of tumorigenicity 18, [RH, Score=124, Expect=1e-29]} {Dmel: FBgn0263772, CG43689, [Score=87.0, Expect=1e-17]} {Celegans: WBGene00009939, ztf-11, Zinc finger putative Transcription Factor family, [RH, Score=124, Expect=2e-30]} {Smed: dd_Smed_v6_80183_0_1, dd_Smed_v6_80183_0_1, [RH, Score=133, Expect=3e-35]} {RNA1310_120779} |
12. | MligTC455_17579 | 76 | 1.58 | Mlig455_042836, Mlig455_045854, Mlig455_045870 | Neo: - Age: - |
RNF217 | 1.885 | - | - | - | 0.924 | - | 0.961 | Mlig455_042836 {REF} {Length: 3004} {Pfam: IBR domain, a half RING-finger domain [PF01485.23, score=75.3]} {Human: ENSG00000146373, RNF217, ring finger protein 217, [Score=83.6, Expect=5e-16]} {Mouse: ENSMUSG00000063760, Rnf217, ring finger protein 217, [Score=83.2, Expect=4e-16]} {Dmel: FBgn0036082, CG12362, [Score=57.0, Expect=4e-08]} {Celegans: WBGene00020462, T12E12.1, Potential E3 ubiquitin-protein ligase ariadne-2, [Score=57.0, Expect=4e-08]} {Smed: dd_Smed_v6_7986_0_1, dd_Smed_v6_7986_0_1, [Score=61.2, Expect=1e-09]} {RNA1310_42946} {RNA815_24345} Mlig455_045854 {REF} {Length: 3004} {Pfam: IBR domain, a half RING-finger domain [PF01485.23, score=74.7]} {Human: ENSG00000146373, RNF217, ring finger protein 217, [Score=83.2, Expect=5e-16]} {Mouse: ENSMUSG00000063760, Rnf217, ring finger protein 217, [Score=83.2, Expect=4e-16]} {Dmel: FBgn0036082, CG12362, [Score=57.4, Expect=3e-08]} {Celegans: WBGene00020462, T12E12.1, Potential E3 ubiquitin-protein ligase ariadne-2, [Score=57.8, Expect=2e-08]} {Smed: dd_Smed_v6_7986_0_1, dd_Smed_v6_7986_0_1, [Score=61.2, Expect=1e-09]} {RNA1310_42946} {RNA815_24345} Mlig455_045870 {REF} {Length: 3004} {Pfam: IBR domain, a half RING-finger domain [PF01485.23, score=74.9]} {Human: ENSG00000146373, RNF217, ring finger protein 217, [Score=83.2, Expect=5e-16]} {Mouse: ENSMUSG00000063760, Rnf217, ring finger protein 217, [Score=83.2, Expect=4e-16]} {Dmel: FBgn0036082, CG12362, [Score=57.4, Expect=3e-08]} {Celegans: WBGene00020462, T12E12.1, Potential E3 ubiquitin-protein ligase ariadne-2, [Score=57.0, Expect=4e-08]} {Smed: dd_Smed_v6_7986_0_1, dd_Smed_v6_7986_0_1, [Score=61.2, Expect=1e-09]} {RNA1310_42946} {RNA815_24345} |
13. | MligTC455_43962 | 120 | 2.5 | Mlig455_020783 | Neo: - Age: - |
TRAF5 | 1.879 | - | - | - | 0.907 | - | 0.972 | Mlig455_020783 {REF} {Length: 3242} {Human: ENSG00000082512, TRAF5, TNF receptor associated factor 5, [Score=90.5, Expect=3e-20]} {Mouse: ENSMUSG00000026637, Traf5, TNF receptor-associated factor 5, [Score=88.6, Expect=1e-20]; ENSMUSG00000111385, Traf5, TNF receptor-associated factor 5, [Score=88.6, Expect=1e-20]} {Dmel: FBgn0026319, Traf4, TNF-receptor-associated factor 4, [Score=70.9, Expect=6e-14]} {Celegans: WBGene00006612, trf-1, TNF Receptor Associated Factor (TRAF) homolog; TRF-1, [Score=99.0, Expect=8e-24]} {Smed: dd_Smed_v6_13517_0_1, dd_Smed_v6_13517_0_1, [Score=132, Expect=8e-36]} {RNA1310_36792.1} {RNA815_40908} |
14. | MligTC455_46894 | 109 | 2.26 | Mlig455_017820 | Neo: - Age: - |
SCRT1 | 1.866 | - | - | 0.959 | - | - | 0.907 | Mlig455_017820 {REF} {Length: 2221} {Pfam: Zinc finger, C2H2 type [PF00096.28, score=84.8]; C2H2-type zinc finger [PF13894.8, score=67.2]; Zinc-finger double domain [PF13465.8, score=60.4]; C2H2-type zinc finger [PF13912.8, score=33.8]; Zinc ribbon domain [PF09723.12, score=21.4]} {Human: ENSG00000261678, SCRT1, scratch family transcriptional repressor 1, [RH, Score=252, Expect=1e-78]; ENSG00000284923, SCRT1, scratch family transcriptional repressor 1, [RH, Score=252, Expect=1e-78]; ENSG00000215397, SCRT2, scratch family transcriptional repressor 2, [RH, Score=247, Expect=2e-77]} {Mouse: ENSMUSG00000048385, Scrt1, scratch family zinc finger 1, [RH, Score=261, Expect=2e-82]; ENSMUSG00000060257, Scrt2, scratch family zinc finger 2, [RH, Score=255, Expect=2e-80]} {Dmel: FBgn0004880, scrt, scratch, [RH, Score=279, Expect=8e-86]} {Celegans: WBGene00000468, ces-1, CES-1; CEll death Specification, [RH, Score=219, Expect=1e-67]} {Smed: dd_Smed_v6_18952_0_1, dd_Smed_v6_18952_0_1, [RH, Score=291, Expect=5e-94]} {RNA1310_21478.1} {RNA815_23567} |
15. | MligTC455_49094 | 59 | 1.22 | Mlig455_065396 | Neo: - Age: - |
RERGL | 1.862 | 0.961 | - | - | - | - | 0.901 | Mlig455_065396 {REF} {Length: 1449} {TRANSSPLICED} {Pfam: Ras family [PF00071.24, score=61.9]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=25.4]} {Human: ENSG00000111404, RERGL, RERG like, [Score=80.5, Expect=7e-18]; ENSG00000134533, RERG, RAS like estrogen regulated growth inhibitor, [Score=80.1, Expect=7e-18]} {Mouse: ENSMUSG00000092164, Rergl, RERG/RAS-like, [Score=84.7, Expect=1e-19]} {Dmel: FBgn0035711, CG8519, [Score=69.3, Expect=4e-14]} {Celegans: WBGene00004309, rap-3, RAP homolog (Vertebrate Rap GTPase family), [Score=59.3, Expect=1e-10]} {Smed: dd_Smed_v6_7273_0_1, dd_Smed_v6_7273_0_1, [Score=80.1, Expect=3e-18]} {RNA1509_41924} {RNA1310_34154} {RNA815_43516} |
16. | MligTC455_11823 | 56 | 1.17 | Mlig455_032181, Mlig455_051196 | Neo: - Age: - |
NPAS1 | 1.86 | 0.898 | - | - | 0.962 | - | - | Mlig455_032181 {REF} {Length: 1417} {Pfam: PAS fold [PF08447.14, score=26.5]; PAS fold [PF00989.27, score=24.6]} {Human: ENSG00000130751, NPAS1, neuronal PAS domain protein 1, [Score=184, Expect=4e-52]; ENSG00000151322, NPAS3, neuronal PAS domain protein 3, [Score=182, Expect=7e-50]} {Mouse: ENSMUSG00000001988, Npas1, neuronal PAS domain protein 1, [Score=183, Expect=7e-52]; ENSMUSG00000021010, Npas3, neuronal PAS domain protein 3, [Score=181, Expect=9e-50]} {Dmel: FBgn0262139, trh, trachealess, [Score=192, Expect=1e-53]} {Celegans: WBGene00011327, hlh-34, Helix-loop-helix 34, [Score=97.1, Expect=2e-22]} {Smed: dd_Smed_v6_17731_0_1, dd_Smed_v6_17731_0_1, [Score=160, Expect=2e-43]} {RNA1310_121098} {RNA815_58328} Mlig455_051196 {REF} {Length: 1417} {Pfam: PAS fold [PF08447.14, score=26.5]; PAS fold [PF00989.27, score=24.6]} {Human: ENSG00000130751, NPAS1, neuronal PAS domain protein 1, [Score=184, Expect=4e-52]; ENSG00000151322, NPAS3, neuronal PAS domain protein 3, [Score=182, Expect=7e-50]} {Mouse: ENSMUSG00000001988, Npas1, neuronal PAS domain protein 1, [Score=183, Expect=7e-52]; ENSMUSG00000021010, Npas3, neuronal PAS domain protein 3, [Score=181, Expect=9e-50]} {Dmel: FBgn0262139, trh, trachealess, [Score=192, Expect=1e-53]} {Celegans: WBGene00011327, hlh-34, Helix-loop-helix 34, [Score=97.1, Expect=2e-22]} {Smed: dd_Smed_v6_17731_0_1, dd_Smed_v6_17731_0_1, [Score=160, Expect=2e-43]} {RNA1310_121098} {RNA815_58328} |
17. | MligTC455_42314 | 406 | 8.46 | Mlig455_052727 | Neo: - Age: - Region-enriched R2: 4.230/0.00183 |
1.853 | - | - | - | 0.871 | - | 0.982 | Mlig455_052727 {REF} {Length: 1339} {Pfam: Hyaluronidase protein (HylP) [PF07212.13, score=19.1]} {RNA1509_51722} {RNA1310_50605} {RNA815_15783.1} | |
18. | MligTC455_39813 | 75 | 1.57 | Mlig455_045961 | Neo: - Age: - |
SLC17A8 | 1.846 | 0.874 | - | 0.972 | - | - | - | Mlig455_045961 {REF} {Length: 3015} {Pfam: Major Facilitator Superfamily [PF07690.18, score=170.7]; Uncharacterised MFS-type transporter YbfB [PF06779.16, score=20.5]} {Human: ENSG00000179520, SLC17A8, solute carrier family 17 member 8, [RH, Score=540, Expect=0.0]; ENSG00000091664, SLC17A6, solute carrier family 17 member 6, [RH, Score=540, Expect=0.0]; ENSG00000104888, SLC17A7, solute carrier family 17 member 7, [RH, Score=529, Expect=0.0]} {Mouse: ENSMUSG00000019935, Slc17a8, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8, [RH, Score=543, Expect=0.0]; ENSMUSG00000030500, Slc17a6, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6, [RH, Score=541, Expect=0.0]; ENSMUSG00000070570, Slc17a7, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7, [RH, Score=528, Expect=0.0]} {Dmel: FBgn0031424, VGlut, Vesicular glutamate transporter, [RH, Score=492, Expect=1e-166]} {Celegans: WBGene00001135, eat-4, Probable vesicular glutamate transporter eat-4, [RH, Score=476, Expect=2e-161]} {Smed: dd_Smed_v6_10192_0_1, dd_Smed_v6_10192_0_1, [RH, Score=588, Expect=0.0]} {RNA1509_53919} {RNA1310_33327} {RNA815_42042} |
19. | MligTC455_14600 | 206 | 4.29 | Mlig455_038122, Mlig455_039790 | Neo: - Age: - Region-enriched R8: 4.975/0.00049 |
IGFALS | 1.834 | 0.876 | - | - | - | - | 0.958 | Mlig455_038122 {REF} {Length: 2842} {Pfam: Leucine rich repeat [PF13855.8, score=265.7]; Leucine Rich repeats (2 copies) [PF12799.9, score=153.7]; Leucine-rich repeat [PF14580.8, score=67.1]; BspA type Leucine rich repeat region (6 copies) [PF13306.8, score=59.8]; Leucine Rich Repeat [PF00560.35, score=56.6]; Leucine Rich repeat [PF13516.8, score=43.5]} {Human: ENSG00000099769, IGFALS, insulin like growth factor binding protein acid labile subunit, [Score=156, Expect=3e-39]} {Mouse: ENSMUSG00000046070, Igfals, insulin-like growth factor binding protein, acid labile subunit, [RH, Score=160, Expect=8e-41]} {Dmel: FBgn0261269, conv, convoluted, [RH, Score=136, Expect=2e-32]} {Celegans: WBGene00016974, lron-15, ELRR (Extracellular Leucine-Rich Repeat) ONly, [RH, Score=149, Expect=1e-36]} {Smed: dd_Smed_v6_2769_0_1, dd_Smed_v6_2769_0_1, [RH, Score=95.9, Expect=2e-20]} {RNA1310_36223} {RNA815_24524} Mlig455_039790 {REF} {Length: 2820} {Pfam: Leucine rich repeat [PF13855.8, score=265.7]; Leucine Rich repeats (2 copies) [PF12799.9, score=153.7]; Leucine-rich repeat [PF14580.8, score=67.1]; BspA type Leucine rich repeat region (6 copies) [PF13306.8, score=59.8]; Leucine Rich Repeat [PF00560.35, score=56.6]; Leucine Rich repeat [PF13516.8, score=43.5]} {Human: ENSG00000099769, IGFALS, insulin like growth factor binding protein acid labile subunit, [Score=156, Expect=3e-39]} {Mouse: ENSMUSG00000046070, Igfals, insulin-like growth factor binding protein, acid labile subunit, [RH, Score=160, Expect=7e-41]} {Dmel: FBgn0261269, conv, convoluted, [RH, Score=135, Expect=2e-32]} {Celegans: WBGene00016974, lron-15, ELRR (Extracellular Leucine-Rich Repeat) ONly, [RH, Score=149, Expect=1e-36]} {Smed: dd_Smed_v6_2769_0_1, dd_Smed_v6_2769_0_1, [RH, Score=96.3, Expect=2e-20]} {RNA1310_36223} {RNA815_24524} |
20. | MligTC455_48713 | 380 | 7.92 | Mlig455_009259, Mlig455_009268 | Neo: - Age: Down-Up-Down Region-specific R2: 6.962 Region-enriched R2: 4.845/0.00046 |
1.828 | - | - | - | 0.852 | - | 0.976 | Mlig455_009259 {REF} {Length: 654} {RNA1509_35038} {RNA1310_72135} {RNA815_37404} Mlig455_009268 {REF} {Length: 546} {RNA1509_35038} {RNA1310_72135, RNA1509_35038} {RNA1509_35038, RNA815_37404} |
|
21. | MligTC455_29118 | 467 | 9.72 | Mlig455_040411 | Neo: - Age: - Region-specific R2: 6.456 Region-enriched R2: 5.344/0.00023 |
1.825 | - | - | - | 0.865 | - | 0.960 | Mlig455_040411 {REF} {Length: 599} {TRANSSPLICED} {RNA1509_53840} {RNA1310_67192, RNA1509_53840} {RNA1509_53840, RNA815_27042} | |
22. | MligTC455_12451 | 63 | 1.31 | Mlig455_008444 | Neo: - Age: - Region-enriched R8: 4.645/0.00722 |
1.815 | 0.970 | - | - | - | - | 0.845 | Mlig455_008444 {REF} {Length: 791} | |
23. | MligTC455_14306 | 49 | 1.02 | Mlig455_040652, Mlig455_062065 | Neo: - Age: - |
1.809 | - | - | 0.952 | 0.857 | - | - | Mlig455_040652 {REF} {Length: 1154} {NoTransDecoderORF} {RNA1509_52052} {RNA1310_51938} {RNA815_453.1} Mlig455_062065 {REF} {Length: 1349} {NoTransDecoderORF} {RNA1509_52052} {RNA1310_51938} {RNA815_453.1} |
|
24. | MligTC455_31764 | 62 | 1.28 | Mlig455_006258 | Neo: - Age: Down-Down-Up Region-enriched R8: 4.078/0.01607 |
LMNA | 1.808 | 0.975 | - | 0.833 | - | - | - | Mlig455_006258 {REF} {Length: 2636} {Pfam: Intermediate filament protein [PF00038.23, score=111.4]} {Human: ENSG00000160789, LMNA, lamin A/C, [Score=87.8, Expect=7e-18]; ENSG00000026025, VIM, vimentin, [Score=84.7, Expect=4e-17]} {Mouse: ENSMUSG00000028063, Lmna, lamin A, [Score=86.3, Expect=2e-17]; ENSMUSG00000026728, Vim, vimentin, [Score=85.5, Expect=2e-17]; ENSMUSG00000095241, Gm5478, predicted pseudogene 5478, [Score=82.8, Expect=2e-16]} {Dmel: FBgn0010397, LamC, Lamin C, [Score=93.6, Expect=5e-20]} {Celegans: WBGene00002050, ifa-1, Intermediate filament protein ifa-1, [Score=165, Expect=1e-44]} {Smed: dd_Smed_v6_3871_0_1, dd_Smed_v6_3871_0_1, [Score=190, Expect=6e-54]} {RNA1509_56508} {RNA1310_5840} {RNA815_9167} |
25. | MligTC455_13424 | 708 | 14.75 | Mlig455_044367 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.089 Region-enriched R7: 4.024/0.00101 |
1.8 | - | - | - | 0.810 | - | 0.990 | Mlig455_044367 {REF} {Length: 633} {RNA1509_34081, RNA1509_52094} {RNA1310_75122.1, RNA1509_34081, RNA1509_52094} {RNA1509_34081, RNA1509_52094, RNA815_57840} | |
26. | MligTC455_13423 | 1243 | 25.9 | Mlig455_044368 | Neo: - Age: logFC(26M/2M)=-0.595 Region-enriched R7: 3.345/0.00033 Regeneration-downregulated BL: -4.170 Regeneration-depleted BL: -4.170 |
1.798 | - | - | - | 0.804 | - | 0.994 | Mlig455_044368 {REF} {Length: 544} {RNA1509_13677} {RNA1310_82629.1, RNA1509_13677} {RNA1509_13677, RNA815_40883} | |
27. | MligTC455_40863 | 70 | 1.46 | Mlig455_014267 | Neo: - Age: Up-Down-Down |
PCDH1 | 1.787 | 0.829 | - | - | 0.958 | - | - | Mlig455_014267 {REF} {Length: 5379} {Pfam: Cadherin domain [PF00028.19, score=328.1]; Cadherin-like [PF16184.7, score=31.3]; Cadherin-like [PF08266.14, score=29.2]} {Human: ENSG00000156453, PCDH1, protocadherin 1, [RH, Score=298, Expect=2e-84]} {Mouse: ENSMUSG00000051375, Pcdh1, protocadherin 1, [RH, Score=300, Expect=3e-85]} {Dmel: FBgn0284247, ds, dachsous, [Score=269, Expect=2e-73]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=197, Expect=6e-51]} {Smed: dd_Smed_v6_14117_0_1, dd_Smed_v6_14117_0_1, [Score=404, Expect=8e-123]} {RNA1310_32856} {RNA815_39004} |
28. | MligTC455_18384 | 52 | 1.08 | Mlig455_033464, Mlig455_033480 | Neo: - Age: - |
CHRNB3 | 1.779 | 0.952 | - | - | - | - | 0.827 | Mlig455_033464 {REF} {Length: 3273} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=101.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=28.0]} {Human: ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=112, Expect=2e-26]} {Mouse: ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=107, Expect=4e-25]; ENSMUSG00000035594, Chrna5, cholinergic receptor, nicotinic, alpha polypeptide 5, [Score=102, Expect=2e-23]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=95.5, Expect=5e-21]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=98.2, Expect=5e-22]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [Score=90.5, Expect=1e-19]} {RNA1509_28510} {RNA1310_44183.1} {RNA815_32188} Mlig455_033480 {REF} {Length: 904} {RNA1310_131495} |
29. | MligTC455_37537 | 203 | 4.23 | Mlig455_047747 | Neo: - Age: - Region-enriched R8: 3.525/0.01192 |
KCNC2 | 1.769 | 0.977 | - | - | - | - | 0.792 | Mlig455_047747 {REF} {Length: 3532} {Pfam: Ion transport protein [PF00520.33, score=105.8]; BTB/POZ domain [PF02214.24, score=56.8]; Ion channel [PF07885.18, score=52.6]} {Human: ENSG00000166006, KCNC2, potassium voltage-gated channel subfamily C member 2, [Score=216, Expect=4e-60]; ENSG00000129159, KCNC1, potassium voltage-gated channel subfamily C member 1, [Score=215, Expect=5e-60]; ENSG00000116396, KCNC4, potassium voltage-gated channel subfamily C member 4, [Score=207, Expect=1e-56]} {Mouse: ENSMUSG00000035681, Kcnc2, potassium voltage gated channel, Shaw-related subfamily, member 2, [Score=218, Expect=1e-60]; ENSMUSG00000058975, Kcnc1, potassium voltage gated channel, Shaw-related subfamily, member 1, [Score=214, Expect=6e-60]} {Dmel: FBgn0003386, Shaw, Shaker cognate w, [Score=230, Expect=1e-65]} {Celegans: WBGene00001202, egl-36, Potassium voltage-gated channel protein egl-36, [Score=211, Expect=5e-59]} {Smed: dd_Smed_v6_9740_0_2, dd_Smed_v6_9740_0_2, [Score=208, Expect=6e-58]} {RNA1509_26535} {RNA1310_14101} {RNA815_34993} |
30. | MligTC455_48970 | 395 | 8.23 | Mlig455_059350, Mlig455_065583 | Neo: - Age: - |
TCTEX1D2 | 1.762 | 0.801 | - | - | - | - | 0.961 | Mlig455_059350 {REF} {Length: 1002} {Pfam: Tctex-1 family [PF03645.15, score=53.8]} {Human: ENSG00000213123, TCTEX1D2, Tctex1 domain containing 2, [Score=52.4, Expect=3e-08]; ENSG00000275368, TCTE3, t-complex-associated-testis-expressed 3, [Score=50.4, Expect=4e-07]; ENSG00000184786, TCTE3, t-complex-associated-testis-expressed 3, [Score=50.4, Expect=4e-07]} {Mouse: ENSMUSG00000116780, Gm3417, predicted gene 3417, [Score=57.0, Expect=1e-09]; ENSMUSG00000079707, Tcte3, t-complex-associated testis expressed 3, [Score=56.2, Expect=2e-09]; ENSMUSG00000079710, Gm3448, predicted gene 3448, [Score=56.2, Expect=2e-09]} {Dmel: FBgn0033243, CG14763, [Score=57.0, Expect=7e-10]} {Smed: dd_Smed_v6_5494_0_1, dd_Smed_v6_5494_0_1, [Score=58.9, Expect=7e-11]} {RNA1310_37058} {RNA815_47054} Mlig455_065583 {REF} {Length: 1105} {Pfam: Tctex-1 family [PF03645.15, score=53.5]} {Human: ENSG00000213123, TCTEX1D2, Tctex1 domain containing 2, [Score=54.3, Expect=9e-09]} {Mouse: ENSMUSG00000116780, Gm3417, predicted gene 3417, [Score=58.9, Expect=3e-10]; ENSMUSG00000079707, Tcte3, t-complex-associated testis expressed 3, [Score=58.2, Expect=6e-10]; ENSMUSG00000079710, Gm3448, predicted gene 3448, [Score=58.2, Expect=6e-10]} {Dmel: FBgn0033243, CG14763, [Score=57.4, Expect=8e-10]} {Smed: dd_Smed_v6_5494_0_1, dd_Smed_v6_5494_0_1, [Score=58.2, Expect=2e-10]} {RNA1310_37058} {RNA815_47054} |
31. | MligTC455_48714 | 132 | 2.74 | Mlig455_037041 | Neo: - Age: - Region-enriched R2: 4.531/0.00493 |
1.755 | - | - | - | 0.777 | - | 0.978 | Mlig455_037041 {REF} {Length: 1099} {RNA1509_35038} {RNA1310_72135} {RNA815_37404} | |
32. | MligTC455_13917 | 50 | 1.05 | Mlig455_006935, Mlig455_017950 | Neo: - Age: - |
1.751 | 0.792 | - | - | - | - | 0.959 | Mlig455_006935 {REF} {Length: 1553} {RNA1310_24840} {RNA815_41829} Mlig455_017950 {REF} {Length: 1661} {RNA1310_24840} {RNA815_41829} |
|
33. | MligTC455_51664 | 54 | 1.12 | Mlig455_022480 | Neo: - Age: - Region-enriched R8: 5.026/0.00763 |
1.751 | 0.950 | - | 0.801 | - | - | - | Mlig455_022480 {REF} {Length: 1388} {Pfam: F5/8 type C domain [PF00754.27, score=22.0]} {Smed: dd_Smed_v6_36585_0_2, dd_Smed_v6_36585_0_2, [Score=44.7, Expect=1e-05]} {RNA1509_36923} {RNA1310_25963} {RNA815_41480} | |
34. | MligTC455_34727 | 96 | 2 | Mlig455_041259 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-0.811 Region-enriched R8: 4.340/0.01025 |
GLIPR1 | 1.743 | 0.976 | - | - | - | - | 0.767 | Mlig455_041259 {REF} {Length: 5028} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=67.4]} {Human: ENSG00000139278, GLIPR1, GLI pathogenesis related 1, [RH, Score=98.6, Expect=2e-22]} {Mouse: ENSMUSG00000056888, Glipr1, GLI pathogenesis-related 1 (glioma), [RH, Score=107, Expect=7e-26]} {Dmel: FBgn0038126, CG8483, [Score=52.8, Expect=5e-07]} {Celegans: WBGene00003055, lon-1, LONg, [Score=67.0, Expect=6e-12]} {Smed: dd_Smed_v6_681_0_1, dd_Smed_v6_681_0_1, [Score=104, Expect=1e-25]} {RNA1509_36146} {RNA1310_23199} {RNA815_7031} |
35. | MligTC455_23598 | 236 | 4.92 | Mlig455_025573 | Neo: - Age: Up-Down-Down Region-enriched R8: 3.347/0.00904 Regeneration-downregulated BL: -7.152 Regeneration-depleted BL: -7.152 |
FBN1 | 1.727 | 0.962 | - | - | - | - | 0.765 | Mlig455_025573 {REF} {Length: 8300} {Pfam: Calcium-binding EGF domain [PF07645.17, score=308.8]; Complement Clr-like EGF-like [PF12662.9, score=240.6]; Coagulation Factor Xa inhibitory site [PF14670.8, score=137.8]; EGF domain [PF12947.9, score=103.1]; EGF-like domain [PF00008.29, score=67.3]; Human growth factor-like EGF [PF12661.9, score=42.0]; Thrombospondin type 1 domain [PF00090.21, score=27.9]; MSP1 EGF domain 1 [PF12946.9, score=23.5]} {Human: ENSG00000166147, FBN1, fibrillin 1, [Score=274, Expect=5e-73]; ENSG00000138829, FBN2, fibrillin 2, [Score=265, Expect=2e-70]; ENSG00000142449, FBN3, fibrillin 3, [Score=263, Expect=1e-69]} {Mouse: ENSMUSG00000027204, Fbn1, fibrillin 1, [Score=291, Expect=2e-78]} {Dmel: FBgn0035798, frac, faulty attraction, [RH, Score=235, Expect=8e-62]} {Celegans: WBGene00001403, fbl-1, Fibulin-1, [Score=165, Expect=2e-41]} {Smed: dd_Smed_v6_2649_0_2, dd_Smed_v6_2649_0_2, [Score=292, Expect=8e-79]} {RNA1509_13106} {RNA1310_487} {RNA815_5734} |
36. | MligTC455_38657 | 292 | 6.08 | Mlig455_021581 | Neo: - Age: - |
CPLX1 | 1.727 | - | - | - | 0.736 | - | 0.991 | Mlig455_021581 {REF} {Length: 2085} {Pfam: Synaphin protein [PF05835.14, score=132.9]} {Human: ENSG00000168993, CPLX1, complexin 1, [Score=52.4, Expect=8e-09]; ENSG00000145920, CPLX2, complexin 2, [Score=50.8, Expect=1e-08]} {Mouse: ENSMUSG00000033615, Cplx1, complexin 1, [Score=53.5, Expect=2e-09]} {Dmel: FBgn0041605, cpx, complexin, [RH, Score=90.1, Expect=1e-23]} {Celegans: WBGene00022271, cpx-1, Putative complexin-1, [RH, Score=99.4, Expect=2e-27]} {Smed: dd_Smed_v6_9918_0_1, dd_Smed_v6_9918_0_1, [Score=94.4, Expect=2e-25]} {RNA1509_37151, RNA1509_38047} {RNA1310_51275, RNA1509_38047} {RNA1509_38047, RNA815_22799} |
37. | MligTC455_40937 | 61 | 1.28 | Mlig455_002886 | Neo: - Age: - |
1.727 | - | - | - | 0.962 | - | 0.765 | Mlig455_002886 {REF} {Length: 2785} {Pfam: Galactose binding lectin domain [PF02140.20, score=26.2]} {RNA1310_41320} {RNA815_38976} | |
38. | MligTC455_12545 | 37 | 0.76 | Mlig455_069121 | Neo: - Age: - |
1.726 | - | - | - | 0.974 | - | 0.752 | Mlig455_069121 {REF} {Length: 1966} {RNA1310_47776.1} {RNA815_35125} | |
39. | MligTC455_48302 | 45 | 0.93 | Mlig455_056275 | Neo: - Age: - |
CHRNA7 | 1.722 | 0.748 | - | - | - | - | 0.974 | Mlig455_056275 {REF} {Length: 3506} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=176.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=131.0]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=255, Expect=4e-76]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=251, Expect=5e-75]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=250, Expect=2e-74]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=245, Expect=6e-73]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=237, Expect=7e-70]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=234, Expect=6e-69]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=271, Expect=1e-82]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=254, Expect=1e-76]} {Smed: dd_Smed_v6_18201_0_1, dd_Smed_v6_18201_0_1, [Score=471, Expect=8e-158]} {RNA1509_49660} {RNA1310_35095} {RNA815_30373} |
40. | MligTC455_49129 | 26 | 0.53 | Mlig455_063694 | Neo: - Age: - Region-enriched R4: 6.806/0.00453 |
1.707 | - | - | 0.745 | - | - | 0.962 | Mlig455_063694 {REF} {Length: 673} {RNA1310_49755} {RNA815_37218} | |
41. | MligTC455_23599 | 300 | 6.25 | Mlig455_025579 | Neo: - Age: Up-Down-Down Region-enriched R8: 3.645/0.00082 |
FBN2 | 1.704 | 0.967 | - | - | - | - | 0.737 | Mlig455_025579 {REF} {Length: 10696} {Pfam: Calcium-binding EGF domain [PF07645.17, score=312.2]; Complement Clr-like EGF-like [PF12662.9, score=241.1]; Coagulation Factor Xa inhibitory site [PF14670.8, score=125.1]; EGF domain [PF12947.9, score=95.9]; EGF-like domain [PF00008.29, score=59.7]; Human growth factor-like EGF [PF12661.9, score=47.9]; Thrombospondin type 1 domain [PF00090.21, score=28.9]; MSP1 EGF domain 1 [PF12946.9, score=21.3]} {Human: ENSG00000138829, FBN2, fibrillin 2, [Score=250, Expect=2e-65]; ENSG00000166147, FBN1, fibrillin 1, [Score=248, Expect=1e-64]; ENSG00000142449, FBN3, fibrillin 3, [Score=243, Expect=3e-63]} {Mouse: ENSMUSG00000024598, Fbn2, fibrillin 2, [Score=253, Expect=1e-66]; ENSMUSG00000027204, Fbn1, fibrillin 1, [Score=251, Expect=5e-66]} {Dmel: FBgn0035798, frac, faulty attraction, [RH, Score=238, Expect=3e-62]} {Celegans: WBGene00001403, fbl-1, Fibulin-1, [Score=192, Expect=3e-50]} {Smed: dd_Smed_v6_2649_0_2, dd_Smed_v6_2649_0_2, [Score=294, Expect=3e-79]} {RNA1509_13106} {RNA1310_487} {RNA815_5734} |
42. | MligTC455_46052 | 159 | 3.31 | Mlig455_020714 | Neo: - Age: - Region-enriched R2: 2.603/0.01508 |
TRAF5 | 1.69 | - | - | - | 0.737 | - | 0.953 | Mlig455_020714 {REF} {Length: 919} {Human: ENSG00000082512, TRAF5, TNF receptor associated factor 5, [Score=90.5, Expect=3e-20]} {Mouse: ENSMUSG00000111385, Traf5, TNF receptor-associated factor 5, [Score=88.2, Expect=1e-20]; ENSMUSG00000026637, Traf5, TNF receptor-associated factor 5, [Score=88.2, Expect=1e-20]} {Dmel: FBgn0026319, Traf4, TNF-receptor-associated factor 4, [Score=73.6, Expect=8e-15]} {Celegans: WBGene00006612, trf-1, TNF Receptor Associated Factor (TRAF) homolog; TRF-1, [Score=98.6, Expect=1e-23]} {Smed: dd_Smed_v6_13517_0_1, dd_Smed_v6_13517_0_1, [Score=135, Expect=1e-36]} {RNA1310_36792.1} {RNA815_40908} |
43. | MligTC455_33854 | 41 | 0.85 | Mlig455_031601 | Neo: - Age: - Region-enriched R2: 5.730/0.00808 |
1.681 | - | - | 0.707 | 0.974 | - | - | Mlig455_031601 {REF} {Length: 1072} {RNA1310_42312} {RNA815_56269} | |
44. | MligTC455_13746 | 200 | 4.17 | Mlig455_064975, Mlig455_066810 | Neo: - Age: - Region-enriched R8: 8.067/0.00000 |
1.666 | 0.954 | - | - | - | - | 0.712 | Mlig455_064975 {REF} {Length: 2922} {RNA1509_22976} {RNA1310_9502} {RNA815_8881} Mlig455_066810 {REF} {Length: 2922} {RNA1509_22976} {RNA1310_9502} {RNA815_8881} |
|
45. | MligTC455_18320 | 313 | 6.52 | Mlig455_008240, Mlig455_040645 | Neo: - Age: - |
1.666 | 0.713 | - | - | - | - | 0.953 | Mlig455_008240 {REF} {Length: 1585} {RNA1509_51389} {RNA1310_17593, RNA1509_51389} {RNA1509_51389, RNA815_21689} Mlig455_040645 {REF} {Length: 1760} {RNA1509_51389} {RNA1310_17593} {RNA815_21689} |
|
46. | MligTC455_25359 | 89 | 1.85 | Mlig455_026764, Mlig455_051780 | Neo: - Age: - |
0.998 | - | - | - | - | - | 0.998 | Mlig455_026764 {REF} {Length: 465} {RNA1310_85091} Mlig455_051780 {REF} {Length: 1387} {RNA1310_85091} {RNA815_62404} |
|
47. | MligTC455_04119 | 32 | 0.66 | Mlig455_001999, Mlig455_002000, Mlig455_002092, Mlig455_002203 | Neo: - Age: - |
0.995 | - | - | 0.995 | - | - | - | Mlig455_001999 {REF} {Length: 756} {NoTransDecoderORF} Mlig455_002000 {REF} {Length: 1382} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=28.6]} {RNA1310_90701} {RNA815_43200} Mlig455_002092 {REF} {Length: 3588} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=28.6]} {RNA1310_90701} {RNA815_43200} Mlig455_002203 {REF} {Length: 3255} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=28.3]} {RNA1310_90701} {RNA815_43200} |
|
48. | MligTC455_17245 | 52 | 1.09 | Mlig455_045215 | Neo: - Age: Down-Up-Down |
0.991 | - | - | 0.991 | - | - | - | Mlig455_045215 {REF} {Length: 1291} {Pfam: F5/8 type C domain [PF00754.27, score=22.9]} {RNA1509_36923} {RNA1310_35658} {RNA815_46836} | |
49. | MligTC455_10023 | 48 | 0.99 | Mlig455_051817 | Neo: - Age: Down-Up-Down |
0.986 | - | - | - | - | - | 0.986 | Mlig455_051817 {REF} {Length: 3330} {Pfam: Sodium:neurotransmitter symporter family [PF00209.20, score=46.4]} {RNA1310_7348} {RNA815_14995} | |
50. | MligTC455_43912 | 108 | 2.26 | Mlig455_038979 | Neo: - Age: - Region-enriched R8: 3.794/0.00970 |
SNAI2 | 0.982 | 0.982 | - | - | - | - | - | Mlig455_038979 {REF} {Length: 2442} {Pfam: Zinc finger, C2H2 type [PF00096.28, score=89.3]; C2H2-type zinc finger [PF13894.8, score=57.9]; Zinc-finger double domain [PF13465.8, score=53.2]; Zinc-finger of C2H2 type [PF12874.9, score=40.2]; Zinc-finger double-stranded RNA-binding [PF12171.10, score=40.0]; C2H2-type zinc finger [PF13912.8, score=35.8]; C2HE / C2H2 / C2HC zinc-binding finger [PF16278.7, score=24.6]; Zinc ribbon domain [PF09723.12, score=19.4]} {Human: ENSG00000019549, SNAI2, snail family transcriptional repressor 2, [RH, Score=204, Expect=3e-62]} {Mouse: ENSMUSG00000022676, Snai2, snail family zinc finger 2, [RH, Score=202, Expect=6e-62]} {Dmel: FBgn0001983, wor, worniu, [RH, Score=207, Expect=7e-61]} {Celegans: WBGene00019299, snai-1, SNAIl family zinc finger 2 transcription factor homolog, [Score=152, Expect=9e-44]} {Smed: dd_Smed_v6_10216_0_1, dd_Smed_v6_10216_0_1, [RH, Score=204, Expect=3e-62]} {RNA1509_43471} {RNA1310_64158} {RNA815_60731} |
51. | MligTC455_25378 | 134 | 2.8 | Mlig455_016116 | Neo: - Age: - Region-enriched R7: 3.311/0.00287 |
TNS2 | 0.981 | - | - | 0.981 | - | - | - | Mlig455_016116 {REF} {Length: 2694} {Pfam: SH2 domain [PF00017.26, score=30.8]; Phosphotyrosine-binding domain [PF08416.15, score=22.5]} {Human: ENSG00000111077, TNS2, tensin 2, [Score=95.9, Expect=5e-20]} {Mouse: ENSMUSG00000037003, Tns2, tensin 2, [Score=90.1, Expect=2e-18]} {Smed: dd_Smed_v6_4454_0_2, dd_Smed_v6_4454_0_2, [Score=97.4, Expect=3e-21]} {RNA1509_44612} {RNA1310_9162.1} {RNA815_10953} |
52. | MligTC455_33495 | 28 | 0.58 | Mlig455_047292, Mlig455_047342, Mlig455_069323 | Neo: - Age: - |
LHFPL2 | 0.981 | - | - | - | 0.981 | - | - | Mlig455_047292 {REF} {Length: 1105} {RNA1310_118047} Mlig455_047342 {REF} {Length: 1735} {Pfam: Lipoma HMGIC fusion partner-like protein [PF10242.11, score=104.8]; PMP-22/EMP/MP20/Claudin tight junction [PF13903.8, score=30.7]} {Human: ENSG00000145685, LHFPL2, LHFPL tetraspan subfamily member 2, [Score=47.8, Expect=1e-05]} {Mouse: ENSMUSG00000045312, Lhfpl2, lipoma HMGIC fusion partner-like 2, [Score=47.0, Expect=1e-05]} {Smed: dd_Smed_v6_9373_0_1, dd_Smed_v6_9373_0_1, [Score=175, Expect=1e-51]} {RNA1509_30020} {RNA1310_118047} {RNA815_5159.1} Mlig455_069323 {REF} {Length: 886} {RNA1310_118047} |
53. | MligTC455_13522 | 37 | 0.76 | Mlig455_053843 | Neo: - Age: - |
SBK1 | 0.98 | - | - | 0.980 | - | - | - | Mlig455_053843 {REF} {Length: 1643} {Pfam: Protein kinase domain [PF00069.27, score=136.9]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=105.2]; Kinase-like [PF14531.8, score=20.3]} {Human: ENSG00000188322, SBK1, SH3 domain binding kinase 1, [Score=247, Expect=8e-78]} {Mouse: ENSMUSG00000042978, Sbk1, SH3-binding kinase 1, [Score=247, Expect=5e-78]} {Dmel: FBgn0034137, CG4945, [RH, Score=204, Expect=2e-60]} {Celegans: WBGene00012792, Y43D4A.6, [Score=112, Expect=8e-28]} {Smed: dd_Smed_v6_5328_1_1, dd_Smed_v6_5328_1_1, [Score=101, Expect=1e-23]} {RNA1310_55113} |
54. | MligTC455_23309 | 257 | 5.35 | Mlig455_013628 | Neo: - Age: Up-Down-Up |
0.98 | 0.980 | - | - | - | - | - | Mlig455_013628 {REF} {Length: 1039} {RNA1509_48616} {RNA1310_6959, RNA1509_48616} {RNA1509_48616, RNA815_10949} | |
55. | MligTC455_37475 | 14 | 0.29 | Mlig455_068635 | Neo: - Age: - |
0.98 | - | - | 0.980 | - | - | - | Mlig455_068635 {REF} {Length: 2052} {Pfam: Colipase-like [PF15083.8, score=21.8]} {RNA1509_35945} {RNA1310_41936} {RNA815_6613} | |
56. | MligTC455_40767 | 11 | 0.23 | Mlig455_052938 | Neo: - Age: - |
0.98 | - | - | 0.980 | - | - | - | Mlig455_052938 {REF} {Length: 1728} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=26.2]; PAN domain [PF00024.28, score=20.2]} {RNA1509_17891} {RNA1310_58949} {RNA815_4614.1} | |
57. | MligTC455_49188 | 2341 | 48.77 | Mlig455_002269, Mlig455_002314 | Neo: - Age: - Region-enriched R6: 6.536/0.00415 |
0.98 | 0.980 | - | - | - | - | - | Mlig455_002269 {REF} {Length: 959} {RNA1509_43329} {RNA1310_49486} {RNA815_5449} Mlig455_002314 {REF} {Length: 1882} {RNA1509_18874, RNA1509_2814, RNA1509_43329} {RNA1310_49486, RNA1509_18874, RNA1509_2814, RNA1509_43329} {RNA1509_18874, RNA1509_2814, RNA1509_43329, RNA815_5449} |
|
58. | MligTC455_51066 | 526 | 10.97 | Mlig455_044665, Mlig455_044724 | Neo: - Age: Down-Up-Down Region-enriched R8: 5.381/0.00000 |
0.98 | - | - | - | - | - | 0.980 | Mlig455_044665 {REF} {Length: 1268} {Smed: dd_Smed_v6_7581_0_1, dd_Smed_v6_7581_0_1, [Score=148, Expect=3e-41]} {RNA1310_47069.2} {RNA815_30975} Mlig455_044724 {REF} {Length: 1327} {Smed: dd_Smed_v6_7581_0_1, dd_Smed_v6_7581_0_1, [Score=148, Expect=3e-41]} {RNA1310_47069.2} {RNA815_30975} |
|
59. | MligTC455_33202 | 92 | 1.92 | Mlig455_016989, Mlig455_021240, Mlig455_062989 | Neo: - Age: - |
FCN2 | 0.977 | 0.977 | - | - | - | - | - | Mlig455_016989 {REF} {Length: 3214} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=143.0]} {Human: ENSG00000160339, FCN2, ficolin 2, [Score=135, Expect=2e-37]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=130, Expect=5e-34]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=128, Expect=1e-33]; ENSMUSG00000026938, Fcna, ficolin A, [Score=126, Expect=1e-33]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=125, Expect=2e-32]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=124, Expect=5e-32]; ENSMUSG00000026835, Fcnb, ficolin B, [Score=122, Expect=2e-32]} {Dmel: FBgn0034160, CG5550, [RH, Score=136, Expect=2e-38]} {Celegans: WBGene00017013, ensh-1, [RH, Score=66.2, Expect=4e-12]} {Smed: dd_Smed_v6_74244_0_1, dd_Smed_v6_74244_0_1, [Score=46.2, Expect=1e-06]} {RNA1509_26827} {RNA1310_48119} {RNA815_52558} Mlig455_021240 {REF} {Length: 2191} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=112.3]} {Human: ENSG00000160339, FCN2, ficolin 2, [Score=104, Expect=6e-26]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=99.0, Expect=3e-23]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=98.2, Expect=4e-23]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=97.4, Expect=7e-23]; ENSMUSG00000026938, Fcna, ficolin A, [Score=97.1, Expect=3e-23]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=95.5, Expect=3e-22]; ENSMUSG00000042436, Mfap4, microfibrillar-associated protein 4, [Score=94.4, Expect=1e-22]; ENSMUSG00000026835, Fcnb, ficolin B, [Score=93.6, Expect=4e-22]} {Dmel: FBgn0034160, CG5550, [Score=104, Expect=9e-27]} {Celegans: WBGene00017013, ensh-1, [Score=52.8, Expect=8e-08]} {Smed: dd_Smed_v6_74244_0_1, dd_Smed_v6_74244_0_1, [Score=46.6, Expect=8e-07]} {RNA1509_26827} {RNA1310_48119} {RNA815_52558} Mlig455_062989 {REF} {Length: 1896} {NoTransDecoderORF} {RNA1509_54825} {RNA1310_118627, RNA1509_54825} {RNA1509_54825, RNA815_47526} |
60. | MligTC455_34728 | 30 | 0.63 | Mlig455_053077 | Neo: - Age: - |
GLIPR1 | 0.977 | - | - | - | - | - | 0.977 | Mlig455_053077 {REF} {Length: 3064} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=66.5]} {Human: ENSG00000139278, GLIPR1, GLI pathogenesis related 1, [RH, Score=99.0, Expect=2e-22]} {Mouse: ENSMUSG00000056888, Glipr1, GLI pathogenesis-related 1 (glioma), [RH, Score=107, Expect=6e-26]} {Dmel: FBgn0038126, CG8483, [Score=53.1, Expect=4e-07]} {Celegans: WBGene00003055, lon-1, LONg, [Score=67.0, Expect=6e-12]} {Smed: dd_Smed_v6_681_0_1, dd_Smed_v6_681_0_1, [Score=104, Expect=1e-25]} {RNA1310_23199} {RNA815_7031} |
61. | MligTC455_39857 | 27 | 0.55 | Mlig455_037127 | Neo: - Age: Down-Down-Down |
NECAB1 | 0.977 | - | - | - | 0.977 | - | - | Mlig455_037127 {REF} {Length: 1710} {Pfam: EF-hand domain [PF13405.8, score=34.9]; EF hand [PF00036.34, score=33.1]; EF-hand domain pair [PF13499.8, score=27.6]; EF-hand domain pair [PF13833.8, score=27.3]; Antibiotic biosynthesis monooxygenase [PF03992.18, score=25.2]; EF hand [PF13202.8, score=23.2]} {Human: ENSG00000123119, NECAB1, N-terminal EF-hand calcium binding protein 1, [Score=186, Expect=7e-55]} {Mouse: ENSMUSG00000040536, Necab1, N-terminal EF-hand calcium binding protein 1, [Score=180, Expect=7e-53]} {RNA1310_5770} {RNA815_27367} |
62. | MligTC455_02209 | 16 | 0.33 | Mlig455_008646 | Neo: - Age: - |
0.973 | - | - | - | - | - | 0.973 | Mlig455_008646 {REF} {Length: 969} {RNA1310_71752} {RNA815_58220} | |
63. | MligTC455_18569 | 79 | 1.65 | Mlig455_002173, Mlig455_002274, Mlig455_002318 | Neo: - Age: - Region-enriched R4: 6.510/0.00058 |
0.972 | - | - | - | - | - | 0.972 | Mlig455_002173 {REF} {Length: 1129} {NoTransDecoderORF} {RNA1509_52353} {RNA1310_130608} {RNA815_60304} Mlig455_002274 {REF} {Length: 1130} {NoTransDecoderORF} {RNA1509_52353} {RNA1310_130608} {RNA815_60304} Mlig455_002318 {REF} {Length: 1012} {NoTransDecoderORF} {RNA1509_52353} {RNA1310_130608} {RNA815_60304} |
|
64. | MligTC455_07515 | 13 | 0.27 | Mlig455_048357 | Neo: - Age: - |
HCRTR1 | 0.971 | - | - | - | - | - | 0.971 | Mlig455_048357 {REF} {Length: 1740} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=51.8]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=38.9]} {Human: ENSG00000121764, HCRTR1, hypocretin receptor 1, [Score=49.7, Expect=6e-06]} {Mouse: ENSMUSG00000028778, Hcrtr1, hypocretin (orexin) receptor 1, [Score=49.7, Expect=4e-06]} {Dmel: FBgn0029723, Proc-R, Proctolin receptor, [Score=52.0, Expect=5e-07]} {Smed: dd_Smed_v6_27761_0_1, dd_Smed_v6_27761_0_1, [Score=103, Expect=3e-24]} {RNA1509_33416} {RNA1310_68701} |
65. | MligTC455_17557 | 200 | 4.16 | Mlig455_022008, Mlig455_058846 | Neo: - Age: - |
0.971 | 0.971 | - | - | - | - | - | Mlig455_022008 {REF} {Length: 1560} {TRANSSPLICED} {Pfam: Tap RepA1 leader peptide [PF08048.14, score=36.1]} {Mouse: ENSMUSG00000050463, Krt78, keratin 78, [Score=82.0, Expect=2e-16]} {RNA1509_27850} {RNA1310_61376.1} {RNA815_49532} Mlig455_058846 {REF} {Length: 1582} {TRANSSPLICED} {Pfam: Tap RepA1 leader peptide [PF08048.14, score=35.1]} {RNA1509_27850} {RNA1310_61376.1, RNA1509_27850} {RNA1509_27850, RNA815_49532} |
|
66. | MligTC455_27468 | 40 | 0.84 | Mlig455_013749 | Neo: - Age: - |
LNPEP | 0.971 | - | - | - | - | - | 0.971 | Mlig455_013749 {REF} {Length: 4937} {Pfam: Peptidase family M1 domain [PF01433.22, score=195.1]; Peptidase M1 N-terminal domain [PF17900.3, score=121.7]} {Human: ENSG00000113441, LNPEP, leucyl and cystinyl aminopeptidase, [Score=289, Expect=5e-85]; ENSG00000172901, LVRN, laeverin, [Score=282, Expect=1e-82]; ENSG00000166825, ANPEP, alanyl aminopeptidase, membrane, [Score=277, Expect=4e-81]; ENSG00000164307, ERAP1, endoplasmic reticulum aminopeptidase 1, [Score=275, Expect=3e-80]} {Mouse: ENSMUSG00000023845, Lnpep, leucyl/cystinyl aminopeptidase, [Score=286, Expect=2e-84]} {Dmel: FBgn0052473, CG32473, [Score=293, Expect=9e-88]} {Celegans: WBGene00003914, pam-1, Aminopeptidase, [Score=251, Expect=2e-72]} {Smed: dd_Smed_v6_6470_0_1, dd_Smed_v6_6470_0_1, [Score=328, Expect=5e-100]} {RNA1509_14706} {RNA1310_6661.1} {RNA815_1900.2} |
67. | MligTC455_50003 | 22 | 0.47 | Mlig455_011553 | Neo: - Age: - |
0.971 | 0.971 | - | - | - | - | - | Mlig455_011553 {REF} {Length: 3370} {Pfam: EF-hand domain pair [PF13499.8, score=30.1]; Family of unknown function (DUF5580) [PF17743.3, score=26.7]; EF-hand domain [PF13405.8, score=21.5]; EF hand [PF00036.34, score=20.7]} {RNA1310_38159} | |
68. | MligTC455_50004 | 22 | 0.47 | Mlig455_051068 | Neo: - Age: - |
0.971 | 0.971 | - | - | - | - | - | Mlig455_051068 {REF} {Length: 2831} {RNA1310_38159} | |
69. | MligTC455_23596 | 522 | 10.87 | Mlig455_000430, Mlig455_000493, Mlig455_000531 | Neo: - |
FAT4 | 0.97 | 0.970 | - | - | - | - | - | Mlig455_000430 {REF} {Length: 4267} {Pfam: Cadherin domain [PF00028.19, score=118.2]; Cadherin-like [PF16184.7, score=29.1]} {Human: ENSG00000196159, FAT4, FAT atypical cadherin 4, [Score=128, Expect=3e-29]; ENSG00000166341, DCHS1, dachsous cadherin-related 1, [Score=127, Expect=6e-29]; ENSG00000120327, PCDHB14, protocadherin beta 14, [Score=123, Expect=2e-28]; ENSG00000143126, CELSR2, cadherin EGF LAG seven-pass G-type receptor 2, [Score=122, Expect=2e-27]} {Mouse: ENSMUSG00000036862, Dchs1, dachsous cadherin related 1, [Score=139, Expect=6e-33]; ENSMUSG00000046743, Fat4, FAT atypical cadherin 4, [Score=138, Expect=2e-32]} {Dmel: FBgn0038439, Cad89D, Cadherin 89D, [Score=160, Expect=9e-40]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=112, Expect=7e-25]} {Smed: dd_Smed_v6_7973_0_1, dd_Smed_v6_7973_0_1, [Score=126, Expect=1e-29]} {RNA1509_18837} {RNA1310_7055.1} {RNA815_6037} Mlig455_000493 {REF} {Length: 4048} {Pfam: Cadherin domain [PF00028.19, score=122.3]; Cadherin-like [PF16184.7, score=30.7]} {Human: ENSG00000196159, FAT4, FAT atypical cadherin 4, [Score=136, Expect=9e-32]; ENSG00000166341, DCHS1, dachsous cadherin-related 1, [Score=133, Expect=7e-31]; ENSG00000120322, PCDHB8, protocadherin beta 8, [Score=131, Expect=1e-30]; ENSG00000120327, PCDHB14, protocadherin beta 14, [Score=130, Expect=1e-30]; ENSG00000107736, CDH23, cadherin related 23, [Score=130, Expect=5e-30]} {Mouse: ENSMUSG00000036862, Dchs1, dachsous cadherin related 1, [Score=146, Expect=4e-35]} {Dmel: FBgn0284247, ds, dachsous, [Score=162, Expect=2e-40]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=120, Expect=2e-27]} {Smed: dd_Smed_v6_7973_0_2, dd_Smed_v6_7973_0_2, [Score=130, Expect=7e-31]} {RNA1509_18837} {RNA1310_7055.1} {RNA815_6037} Mlig455_000531 {REF} {Length: 2574} {RNA1509_18837} {RNA1310_7055.2} {RNA815_17974.1} |
70. | MligTC455_41389 | 111 | 2.31 | Mlig455_024385 | Neo: - Age: - |
0.969 | - | - | - | - | - | 0.969 | Mlig455_024385 {REF} {Length: 569} {NoTransDecoderORF} {RNA1509_15591} {RNA1310_81202.1} {RNA815_31796} | |
71. | MligTC455_03408 | 164 | 3.43 | Mlig455_019140, Mlig455_054281 | Neo: - Age: logFC(26M/2M)=-0.793 |
ATP11A | 0.968 | - | - | - | - | - | 0.968 | Mlig455_019140 {REF} {Length: 422} {TRANSSPLICED} {Pfam: Phospholipid-translocating ATPase N-terminal [PF16209.7, score=69.3]} {Human: ENSG00000068650, ATP11A, ATPase phospholipid transporting 11A, [Score=111, Expect=3e-29]; ENSG00000101974, ATP11C, ATPase phospholipid transporting 11C, [Score=108, Expect=5e-28]; ENSG00000058063, ATP11B, ATPase phospholipid transporting 11B (putative), [Score=106, Expect=2e-29]} {Mouse: ENSMUSG00000031441, Atp11a, ATPase, class VI, type 11A, [Score=112, Expect=7e-31]} {Dmel: FBgn0030747, CG4301, [Score=94.7, Expect=1e-23]} {Celegans: WBGene00019166, tat-2, Phospholipid-transporting ATPase, [Score=66.6, Expect=7e-14]} {Smed: dd_Smed_v6_5121_0_1, dd_Smed_v6_5121_0_1, [Score=95.5, Expect=5e-24]} {RNA1509_53106} {RNA1310_2065} {RNA815_1499} Mlig455_054281 {REF} {Length: 4054} {TRANSSPLICED} {Pfam: Phospholipid-translocating P-type ATPase C-terminal [PF16212.7, score=192.8]; Phospholipid-translocating ATPase N-terminal [PF16209.7, score=64.1]; haloacid dehalogenase-like hydrolase [PF00702.28, score=53.0]; E1-E2 ATPase [PF00122.22, score=51.9]; Cation transport ATPase (P-type) [PF13246.8, score=39.2]} {Human: ENSG00000068650, ATP11A, ATPase phospholipid transporting 11A, [RH, Score=790, Expect=0.0]} {Mouse: ENSMUSG00000037400, Atp11b, ATPase, class VI, type 11B, [Score=802, Expect=0.0]; ENSMUSG00000031441, Atp11a, ATPase, class VI, type 11A, [Score=773, Expect=0.0]} {Dmel: FBgn0030746, CG9981, [RH, Score=560, Expect=0.0]} {Celegans: WBGene00019166, tat-2, Phospholipid-transporting ATPase, [Score=555, Expect=4e-177]} {Smed: dd_Smed_v6_10670_0_1, dd_Smed_v6_10670_0_1, [Score=874, Expect=0.0]} {RNA1509_53106} {RNA1310_2010.1, RNA1509_53106} {RNA1509_53106, RNA815_1499} |
72. | MligTC455_14351 | 20 | 0.42 | Mlig455_033296 | Neo: - Age: - |
0.968 | - | - | - | 0.968 | - | - | Mlig455_033296 {REF} {Length: 904} {NoTransDecoderORF} {RNA1310_77166} {RNA815_51589} | |
73. | MligTC455_41929 | 42 | 0.87 | Mlig455_058092 | Neo: - Age: Down-Up-Down |
0.968 | - | - | - | 0.968 | - | - | Mlig455_058092 {REF} {Length: 1217} {NoTransDecoderORF} {RNA1509_11856} {RNA1310_9867.2} {RNA815_18841.1} | |
74. | MligTC455_12746 | 35 | 0.72 | Mlig455_046035 | Neo: - Age: - |
0.967 | - | - | - | 0.967 | - | - | Mlig455_046035 {REF} {Length: 577} {NoTransDecoderORF} {RNA1509_55375} {RNA1310_61728} {RNA815_38799} | |
75. | MligTC455_22726 | 127 | 2.66 | Mlig455_016193 | Neo: - Age: - |
TMEM216 | 0.967 | - | - | 0.967 | - | - | - | Mlig455_016193 {REF} {Length: 1977} {TRANSSPLICED} {Pfam: Predicted membrane protein [PF09799.11, score=77.3]} {Human: ENSG00000187049, TMEM216, transmembrane protein 216, [Score=48.9, Expect=2e-07]} {Mouse: ENSMUSG00000024667, Tmem216, transmembrane protein 216, [Score=45.8, Expect=1e-06]} {Dmel: FBgn0037615, CG11760, [Score=44.3, Expect=4e-06]} {Smed: dd_Smed_v6_14636_0_1, dd_Smed_v6_14636_0_1, [Score=67.4, Expect=5e-15]} {RNA1310_55880} {RNA815_28195} |
76. | MligTC455_51640 | 166 | 3.46 | Mlig455_051173, Mlig455_062980 | Neo: - Age: - |
0.967 | - | - | - | - | - | 0.967 | Mlig455_051173 {REF} {Length: 1474} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=40.6]; TcdA/TcdB catalytic glycosyltransferase domain [PF12919.9, score=18.3]} {Smed: dd_Smed_v6_2174_0_1, dd_Smed_v6_2174_0_1, [Score=81.6, Expect=2e-17]} {RNA1310_26804} {RNA815_17702} Mlig455_062980 {REF} {Length: 2554} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=40.6]; TcdA/TcdB catalytic glycosyltransferase domain [PF12919.9, score=18.1]} {Smed: dd_Smed_v6_2174_0_1, dd_Smed_v6_2174_0_1, [Score=81.3, Expect=2e-17]} {RNA1310_26804} {RNA815_17702} |
|
77. | MligTC455_23227 | 61 | 1.28 | Mlig455_001505 | Neo: - Age: - |
EPHA7 | 0.966 | 0.966 | - | - | - | - | - | Mlig455_001505 {REF} {Length: 4755} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=295.0]; Protein kinase domain [PF00069.27, score=136.9]; Ephrin receptor ligand binding domain [PF01404.21, score=117.2]; Fibronectin type III domain [PF00041.23, score=79.8]; Ephrin type-A receptor 2 transmembrane domain [PF14575.8, score=70.8]; SAM domain (Sterile alpha motif) [PF07647.19, score=58.4]; SAM domain (Sterile alpha motif) [PF00536.32, score=57.4]; Tyrosine-protein kinase ephrin type A/B receptor-like [PF07699.15, score=26.4]; ABC1 atypical kinase-like domain [PF03109.18, score=22.2]; Lipopolysaccharide kinase (Kdo/WaaP) family [PF06293.16, score=19.5]} {Human: ENSG00000135333, EPHA7, EPH receptor A7, [RH, Score=716, Expect=0.0]; ENSG00000145242, EPHA5, EPH receptor A5, [RH, Score=696, Expect=0.0]; ENSG00000116106, EPHA4, EPH receptor A4, [RH, Score=694, Expect=0.0]} {Mouse: ENSMUSG00000028289, Epha7, Eph receptor A7, [RH, Score=716, Expect=0.0]; ENSMUSG00000026235, Epha4, Eph receptor A4, [RH, Score=697, Expect=0.0]; ENSMUSG00000029245, Epha5, Eph receptor A5, [RH, Score=692, Expect=0.0]} {Dmel: FBgn0025936, Eph, Eph receptor tyrosine kinase, [RH, Score=676, Expect=0.0]} {Celegans: WBGene00006868, vab-1, Ephrin receptor 1, [RH, Score=485, Expect=6e-153]} {Smed: dd_Smed_v6_16928_0_1, dd_Smed_v6_16928_0_1, [RH, Score=579, Expect=0.0]} {RNA1509_51951} {RNA1310_5149.1} {RNA815_23934} |
78. | MligTC455_45620 | 1952 | 40.67 | Mlig455_002357 | Neo: - Age: Down-Up-Up Region-enriched R2: 2.487/0.00094 Regeneration-depleted BL: -3.636 |
0.966 | - | - | - | - | - | 0.966 | Mlig455_002357 {REF} {Length: 933} {RNA1509_8166} {RNA1310_46295} {RNA815_23543} | |
79. | MligTC455_51602 | 235 | 4.9 | Mlig455_046885 | Neo: - Age: - Region-enriched R2: 3.077/0.00701 |
PCBP3 | 0.966 | - | - | - | 0.966 | - | - | Mlig455_046885 {REF} {Length: 3838} {Pfam: KH domain [PF00013.31, score=177.6]; KH domain [PF07650.19, score=58.6]; KH domain [PF13083.8, score=27.1]; KH-like RNA-binding domain [PF16005.7, score=24.6]} {Human: ENSG00000183570, PCBP3, poly(rC) binding protein 3, [Score=305, Expect=3e-98]} {Mouse: ENSMUSG00000001120, Pcbp3, poly(rC) binding protein 3, [Score=298, Expect=1e-95]} {Dmel: FBgn0262737, mub, mushroom-body expressed, [RH, Score=282, Expect=3e-89]} {Celegans: WBGene00003978, pes-4, Patterned Expression Site, [RH, Score=228, Expect=1e-68]} {Smed: dd_Smed_v6_7334_0_1, dd_Smed_v6_7334_0_1, [Score=258, Expect=1e-78]} {RNA1509_47335} {RNA1310_5732, RNA1509_47335} {RNA1509_47335, RNA815_22034} |
80. | MligTC455_30850 | 34 | 0.71 | Mlig455_019341, Mlig455_019556 | Neo: - Age: logFC(26M/2M)=-0.625 |
GRIK2, GRIK4 | 0.965 | 0.965 | - | - | - | - | - | Mlig455_019341 {REF} {Length: 3886} {Pfam: Ligand-gated ion channel [PF00060.28, score=95.5]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=54.6]; Receptor family ligand binding region [PF01094.30, score=53.8]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=24.1]; Iron-containing alcohol dehydrogenase [PF13685.8, score=22.3]} {Human: ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=160, Expect=8e-40]; ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=157, Expect=6e-39]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=152, Expect=3e-37]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=160, Expect=4e-40]; ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=155, Expect=2e-38]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=153, Expect=6e-38]} {Dmel: FBgn0039927, CG11155, [Score=179, Expect=3e-46]} {Celegans: WBGene00001615, glr-4, GLutamate Receptor family (AMPA), [Score=136, Expect=1e-32]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [Score=257, Expect=5e-78]} {RNA1509_10728} {RNA1310_122.1} {RNA815_8415.1} Mlig455_019556 {REF} {Length: 4135} {Pfam: Ligand-gated ion channel [PF00060.28, score=96.3]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=54.5]; Receptor family ligand binding region [PF01094.30, score=39.5]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=24.1]; Iron-containing alcohol dehydrogenase [PF13685.8, score=19.4]} {Human: ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=155, Expect=3e-38]; ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=150, Expect=8e-37]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=149, Expect=2e-36]} {Mouse: ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=154, Expect=5e-38]; ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=149, Expect=1e-36]; ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=149, Expect=1e-36]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=147, Expect=4e-36]} {Dmel: FBgn0039927, CG11155, [Score=169, Expect=3e-43]} {Celegans: WBGene00001615, glr-4, GLutamate Receptor family (AMPA), [Score=136, Expect=1e-32]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [Score=259, Expect=1e-78]} {RNA1509_10728} {RNA1310_31364} {RNA815_8415.1} |
81. | MligTC455_01281 | 31 | 0.65 | Mlig455_024412 | Neo: - Age: - Regeneration-enriched R4: 6.112 |
0.964 | - | - | - | - | - | 0.964 | Mlig455_024412 {REF} {Length: 736} {NoTransDecoderORF} {RNA1310_123524} | |
82. | MligTC455_07504 | 85 | 1.77 | Mlig455_001458 | Neo: - Age: - |
0.964 | - | - | - | - | - | 0.964 | Mlig455_001458 {REF} {Length: 4238} {RNA1310_78279} | |
83. | MligTC455_23308 | 249 | 5.18 | Mlig455_013575 | Neo: - Age: Up-Down-Down |
0.964 | 0.964 | - | - | - | - | - | Mlig455_013575 {REF} {Length: 832} {RNA1509_48616} {RNA1310_6959} {RNA815_10949} | |
84. | MligTC455_46734 | 116 | 2.41 | Mlig455_041816 | Neo: - Age: - |
0.964 | - | - | - | - | - | 0.964 | Mlig455_041816 {REF} {Length: 1415} {RNA1509_50573} {RNA1310_17892.1} {RNA815_32856.1} | |
85. | MligTC455_07309 | 57 | 1.19 | Mlig455_059977 | Neo: - Age: - |
0.963 | - | - | 0.963 | - | - | - | Mlig455_059977 {REF} {Length: 378} {RNA1310_21321} {RNA815_8534} | |
86. | MligTC455_36599 | 36 | 0.75 | Mlig455_030316, Mlig455_034137 | Neo: - Age: - |
0.963 | - | - | - | - | - | 0.963 | Mlig455_030316 {REF} {Length: 755} {NoTransDecoderORF} {RNA1509_51255} {RNA1310_60503} {RNA815_39433} Mlig455_034137 {REF} {Length: 518} {NoTransDecoderORF} {RNA1509_51255} {RNA1310_60503} {RNA815_39433} |
|
87. | MligTC455_33157 | 281 | 5.86 | Mlig455_009092 | Neo: - Age: - |
0.962 | - | - | - | - | - | 0.962 | Mlig455_009092 {REF} {Length: 5302} {RNA1509_51204} {RNA1310_20216} {RNA815_6624} | |
88. | MligTC455_10386 | 40 | 0.84 | Mlig455_016460, Mlig455_016526, Mlig455_049813 | Neo: - Age: Up-Down-Down |
CHRNA2, CHRNA6 | 0.961 | - | - | - | 0.961 | - | - | Mlig455_016460 {REF} {Length: 2441} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=156.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=111.5]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=211, Expect=9e-61]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=209, Expect=4e-60]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=201, Expect=5e-56]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=214, Expect=3e-62]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=211, Expect=1e-60]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=216, Expect=6e-63]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=210, Expect=8e-61]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [RH, Score=439, Expect=5e-148]} {RNA1310_41035} {RNA815_43177} Mlig455_016526 {REF} {Length: 2438} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=156.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=111.5]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=211, Expect=8e-61]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=209, Expect=4e-60]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=201, Expect=6e-56]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=214, Expect=4e-62]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=211, Expect=1e-60]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=216, Expect=6e-63]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=210, Expect=8e-61]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [RH, Score=439, Expect=4e-148]} {RNA1310_41035} {RNA815_43177} Mlig455_049813 {REF} {Length: 2457} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=156.5]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=109.6]} {Human: ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=209, Expect=5e-60]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=207, Expect=1e-59]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=6e-57]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=3e-57]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=5e-57]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=201, Expect=6e-56]} {Mouse: ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=213, Expect=1e-61]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=212, Expect=1e-61]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=204, Expect=2e-58]; ENSMUSG00000027577, Chrna4, cholinergic receptor, nicotinic, alpha polypeptide 4, [Score=203, Expect=6e-57]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=217, Expect=4e-63]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=209, Expect=1e-60]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [RH, Score=439, Expect=3e-148]} {RNA1310_41035} {RNA815_43177} |
89. | MligTC455_52483 | 36 | 0.76 | Mlig455_042704 | Neo: - Age: - |
0.961 | - | - | 0.961 | - | - | - | Mlig455_042704 {REF} {Length: 2647} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=149.0]} {Smed: dd_Smed_v6_31771_0_1, dd_Smed_v6_31771_0_1, [Score=71.2, Expect=7e-13]} {RNA1310_47540} {RNA815_16144} | |
90. | MligTC455_00282 | 64 | 1.34 | Mlig455_011958 | Neo: - Age: - |
0.96 | - | - | - | - | - | 0.960 | Mlig455_011958 {REF} {Length: 258} {NoTransDecoderORF} | |
91. | MligTC455_12170 | 12 | 0.25 | Mlig455_009789, Mlig455_009791 | Neo: - Age: - |
0.96 | - | - | - | - | - | 0.960 | Mlig455_009789 {REF} {Length: 189} {NoTransDecoderORF} Mlig455_009791 {REF} {Length: 1636} {RNA1310_75425} |
|
92. | MligTC455_17918 | 88 | 1.84 | Mlig455_045439 | Neo: - Age: Up-Down-Down |
QTRT2 | 0.96 | - | - | 0.960 | - | - | - | Mlig455_045439 {REF} {Length: 4111} {TRANSSPLICED} {Pfam: Queuine tRNA-ribosyltransferase [PF01702.20, score=160.9]} {Human: ENSG00000151576, QTRT2, queuine tRNA-ribosyltransferase accessory subunit 2, [RH, Score=120, Expect=6e-30]} {Dmel: FBgn0036000, CG3434, [RH, Score=101, Expect=3e-23]} {Celegans: WBGene00006567, tgt-2, Queuine tRNA-ribosyltransferase accessory subunit 2, [RH, Score=97.4, Expect=3e-22]} {Smed: dd_Smed_v6_14819_0_1, dd_Smed_v6_14819_0_1, [RH, Score=117, Expect=3e-29]} {RNA1509_44219} {RNA1310_13396} {RNA815_59864} |
93. | MligTC455_20956 | 77 | 1.6 | Mlig455_008761 | Neo: - Age: Up-Down-Down Region-enriched R8: 3.712/0.03504 |
GLRA3 | 0.96 | 0.960 | - | - | - | - | - | Mlig455_008761 {REF} {Length: 3739} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=146.1]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=124.8]} {Human: ENSG00000145451, GLRA3, glycine receptor alpha 3, [RH, Score=344, Expect=7e-114]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [RH, Score=338, Expect=2e-111]} {Mouse: ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [RH, Score=342, Expect=5e-113]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [RH, Score=336, Expect=7e-111]} {Dmel: FBgn0024963, GluClalpha, [RH, Score=291, Expect=2e-93]} {Celegans: WBGene00001593, glc-3, Glutamate-gated ChLoride channel; Glutamate-gated chloride channel subunit, [RH, Score=256, Expect=7e-80]} {Smed: dd_Smed_v6_10794_0_1, dd_Smed_v6_10794_0_1, [Score=253, Expect=1e-78]} {RNA1310_38552.1} {RNA815_6481} |
94. | MligTC455_33293 | 190 | 3.95 | Mlig455_039617, Mlig455_051433 | Neo: - Age: logFC(26M/2M)=-0.344 |
CERKL | 0.96 | - | - | 0.960 | - | - | - | Mlig455_039617 {REF} {Length: 1308} {RNA1509_27178} {RNA1310_5866.1} {RNA815_1765} Mlig455_051433 {REF} {Length: 4899} {TRANSSPLICED} {Pfam: Diacylglycerol kinase catalytic domain [PF00781.26, score=53.4]; Ceramide kinase C-terminal domain [PF19280.1, score=36.3]} {Human: ENSG00000188452, CERKL, ceramide kinase like, [Score=109, Expect=3e-24]} {Mouse: ENSMUSG00000075256, Cerkl, ceramide kinase-like, [Score=96.7, Expect=2e-20]} {Dmel: FBgn0037315, Cerk, Ceramide kinase, [Score=97.4, Expect=2e-20]} {Smed: dd_Smed_v6_9323_0_1, dd_Smed_v6_9323_0_1, [Score=120, Expect=2e-28]} {RNA1509_12345, RNA1509_27178} {RNA1310_5866.1, RNA1509_12345, RNA1509_27178} {RNA1509_12345, RNA1509_27178, RNA815_1765} |
95. | MligTC455_42514 | 28 | 0.59 | Mlig455_027746 | Neo: - Age: Up-Down-Down |
KCNC2 | 0.96 | - | - | - | 0.960 | - | - | Mlig455_027746 {REF} {Length: 2596} {Pfam: Ion transport protein [PF00520.33, score=123.8]; BTB/POZ domain [PF02214.24, score=86.8]; Ion channel [PF07885.18, score=37.1]} {Human: ENSG00000166006, KCNC2, potassium voltage-gated channel subfamily C member 2, [Score=284, Expect=2e-86]; ENSG00000129159, KCNC1, potassium voltage-gated channel subfamily C member 1, [Score=279, Expect=3e-85]; ENSG00000116396, KCNC4, potassium voltage-gated channel subfamily C member 4, [Score=270, Expect=2e-81]} {Mouse: ENSMUSG00000058975, Kcnc1, potassium voltage gated channel, Shaw-related subfamily, member 1, [Score=279, Expect=3e-85]; ENSMUSG00000035681, Kcnc2, potassium voltage gated channel, Shaw-related subfamily, member 2, [Score=270, Expect=2e-81]} {Dmel: FBgn0003386, Shaw, Shaker cognate w, [Score=280, Expect=7e-87]} {Celegans: WBGene00008819, shw-1, SHaW family of potassium channels, [Score=303, Expect=3e-94]} {Smed: dd_Smed_v6_13250_0_1, dd_Smed_v6_13250_0_1, [Score=286, Expect=3e-88]} {RNA1509_33421} {RNA1310_15684} {RNA815_16308} |
96. | MligTC455_56181 | 29 | 0.6 | Mlig455_020088 | Neo: - Age: - |
0.96 | - | - | - | - | - | 0.960 | Mlig455_020088 {REF} {Length: 619} {NoTransDecoderORF} {RNA1310_136270} | |
97. | MligTC455_43271 | 21 | 0.44 | Mlig455_016226 | Neo: - Age: - |
0.959 | - | - | - | - | - | 0.959 | Mlig455_016226 {REF} {Length: 875} {RNA1310_7789} {RNA815_12366} | |
98. | MligTC455_51195 | 51 | 1.06 | Mlig455_020957 | Neo: - Age: Down-Down-Up |
CDK5R1 | 0.959 | - | - | - | 0.959 | - | - | Mlig455_020957 {REF} {Length: 1912} {Pfam: Cyclin-dependent kinase 5 activator protein [PF03261.17, score=249.3]} {Human: ENSG00000176749, CDK5R1, cyclin dependent kinase 5 regulatory subunit 1, [RH, Score=191, Expect=5e-57]} {Mouse: ENSMUSG00000048895, Cdk5r1, cyclin-dependent kinase 5, regulatory subunit 1 (p35), [RH, Score=191, Expect=4e-57]} {Dmel: FBgn0027491, Cdk5alpha, Cdk5 activator-like protein, [RH, Score=199, Expect=2e-58]} {Celegans: WBGene00011955, cdka-1, Cyclin-dependent kinase 5 activator 1, [RH, Score=176, Expect=5e-51]} {Smed: dd_Smed_v6_13788_0_1, dd_Smed_v6_13788_0_1, [RH, Score=216, Expect=9e-67]} {RNA1509_28436} {RNA1310_14097} {RNA815_13436} |
99. | MligTC455_38031 | 24 | 0.5 | Mlig455_049070 | Neo: - Age: - |
0.958 | - | - | 0.958 | - | - | - | Mlig455_049070 {REF} {Length: 2566} {RNA1310_26848} {RNA815_42675} | |
100. | MligTC455_38826 | 244 | 5.08 | Mlig455_059316 | Neo: - Age: Up-Down-Up Region-enriched R8: 3.511/0.00478 |
RDX | 0.958 | 0.958 | - | - | - | - | - | Mlig455_059316 {REF} {Length: 3395} {Pfam: Ezrin/radixin/moesin family [PF00769.21, score=106.5]; FERM C-terminal PH-like domain [PF09380.12, score=87.8]; FERM central domain [PF00373.20, score=83.0]; FERM N-terminal domain [PF09379.12, score=66.5]} {Human: ENSG00000137710, RDX, radixin, [RH, Score=589, Expect=0.0]; ENSG00000092820, EZR, ezrin, [RH, Score=577, Expect=0.0]; ENSG00000147065, MSN, moesin, [RH, Score=561, Expect=0.0]} {Mouse: ENSMUSG00000032050, Rdx, radixin, [RH, Score=586, Expect=0.0]; ENSMUSG00000031207, Msn, moesin, [RH, Score=557, Expect=0.0]} {Dmel: FBgn0011661, Moe, Moesin, [RH, Score=514, Expect=5e-174]} {Celegans: WBGene00001333, erm-1, ERM-1B; Ezrin/Radixin/Moesin, [Score=545, Expect=0.0]} {Smed: dd_Smed_v6_8101_0_1, dd_Smed_v6_8101_0_1, [Score=504, Expect=7e-172]} {RNA1509_50666} {RNA1310_19690} {RNA815_6880} |